Clinical Trial Update: An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan

View source ↗

Summary

An observational real-world study in Japan examining outcomes for patients with chronic heart failure who start vericiguat treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: Bayer | Conditions: Chronic Heart Failure, Chronic Heart Failure With Reduced Ejection Fraction | Status: COMPLETED